Editor’s summary The primary approach for individuals with celiac disease to manage their symptoms is a strict gluten-free diet, which is both costly and difficult to maintain. Here, Porret et al. report early steps toward another approach to control celiac disease using cell therapy. The authors show that engineered regulatory T cells (eTregs) modified to orthotopically express T cell receptors specific to gluten peptides could quiet gluten-reactive effector T cells in vitro and in vivo.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Itay
Contact Itay, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack